| # | Drug | Count |
|---|---|---|
| 0 | DURVALUMAB | 64 |
| 1 | CARBOPLATIN | 45 |
| 2 | OSIMERTINIB | 44 |
| 3 | PACLITAXEL | 29 |
| 4 | PEMBROLIZUMAB | 28 |
| 5 | PACLITAXEL (AIBUMIN-BOUND) | 27 |
| 6 | PEMETREXED DISODIUM | 27 |
| 7 | PEMETREXED | 19 |
| 8 | GEFITINIB | 18 |
| 9 | NIVOLUMAB | 18 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AMIVANTAMAB AND HYALURONIDASE-LPUJ (HUMAN RECOMBINANT) | 1 | 0.0033 |
| 1 | DURVALUMAB | 64 | 0.0030 |
| 2 | CAPMATINIB | 6 | 0.0025 |
| 3 | MEXILETINE HYDROCHLORIDE | 1 | 0.0024 |
| 4 | LAZERTINIB | 2 | 0.0023 |
| 5 | AMOXAPINE | 1 | 0.0021 |
| 6 | GEFITINIB | 18 | 0.0020 |
| 7 | BRIGATINIB | 7 | 0.0019 |
| 8 | SOTORASIB | 6 | 0.0017 |
| 9 | TREMELIMUMAB | 7 | 0.0016 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Programmed Death Ligand-1 Blocker [EPC] | 64 | 0.0030 |
| 1 | Tricyclic Antidepressant [EPC] | 1 | 0.0021 |
| 2 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 3 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 52 | 0.0005 |
| 4 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 5 | CTLA-4-directed Blocking Antibody [EPC] | 16 | 0.0003 |
| 6 | Microtubule Inhibitor [EPC] | 34 | 0.0002 |
| 7 | Platinum-based Drug [EPC] | 50 | 0.0002 |
| 8 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 1 | 0.0002 |
| 9 | Kinase Inhibitor [EPC] | 73 | 0.0001 |